David F. Jarrard

Also affiliated with University of Wisconsin–Madison, Wisconsin Division of Public Health

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 20 papers. Top paper: “HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer”.

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.6496

N/A

2.3DataRank · unranked

76 citations

Christopher J. Sweeney, Nima Almassi, Chad A. Reichard, C.A. Reddy, Hong Li +9 more

Accurate segmentation of prostate cancer histomorphometric features using a weakly supervised convolutional neural network

Journal of Medical Imaging(2020)10.1117/1.jmi.7.5.057501

N/A

0.385DataRank · unranked

12 citations

Halle Foss, Sean D. McGarry, Allison Lowman, Sarah Hurrell, Kenneth A. Iczkowski +13 more

Screening Hypermethylated Regions by Methylation-Sensitive Single-Strand Conformational Polymorphism

Analytical Biochemistry(2000)10.1006/abio.1999.4445

N/A

0.360DataRank · unranked

10 citations

Yan Shi, Carol Sandefur, David F. Jarrard, Hidefumi Kinoshita

Ten-year survival rates by PSA nadir in patients with metastatic hormone-sensitive prostate cancer: long-term survival analysis from the ECOG-ACRIN 3805 (CHAARTED) trial

Annals of Oncology(2025)10.1016/j.annonc.2025.08.004

N/A

0.345DataRank · unranked

9 citations

Y. Chen, David F. Jarrard, Jorge A. García, R. Dreicer, Guoqiang Liu +12 more

Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)

European Urology Oncology(2024)10.1016/j.euo.2024.04.010

N/A

0.330DataRank · unranked

8 citations

Xiangying Chu, David F. Jarrard, Michael A. Carducci, Robert S. DiPaola, Lynn I. Wagner +4 more

Reversible Epigenetic Alterations Regulate Class I HLA Loss in Prostate Cancer

Research Square(2021)10.21203/rs.3.rs-894353/v1

N/A

0.292DataRank · unranked

6 citations

Erika Henninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison Kircher +8 more

Effect of cerebral dopamine metabolism genetic polymorphism on patient-reported quality-of-life (QOL): An analysis of the E3805 CHAARTED trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.123

N/A

0.104DataRank · unranked

1 citations

Yu‐Hui Chen, Christopher Sweeney, David F. Jarrard, Elizabeth R. Plimack, Benjamin A. Gartrell +7 more

Outcomes of Patients With Localized Renal Cell Carcinoma on Immunosuppression Following Solid Organ Transplantation

Urology(2025)10.1016/j.urology.2025.12.007

N/A

0.104DataRank · unranked

1 citations

E. Jason Abel, Joshua D. Mezrich, Andrew Z. Carey, Amy K. Taylor, Adam Bregman +14 more

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.003

N/A

0.104DataRank · unranked

1 citations

Xiangying Chu, Charles J. Ryan, Arjun Gupta, Christopher J. Sweeney, David F. Jarrard +10 more

Patient reported quality of life (QOL) and survival outcomes: Analysis of ECOG-ACRIN E3805 chemohormonal androgen ablation randomized trial (CHAARTED) in prostate cancer (PCa).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5014

N/A

0DataRank · unranked

0 citations

Xiangying Chu, David F. Jarrard, Michael A. Carducci, Robert S. DiPaola, Lynne I. Wagner +4 more

CTCF loss mediates unique DNA hypermethylation landscapes in human cancers

Clinical Epigenetics(2020)10.1186/s13148-020-00869-7

N/A

0DataRank · unranked

52 citations

Joseph Gawdzik, Mele Avilla, Bing Yang, John Svaren, Avtar Roopra +5 more

Quantifying partial pathological response rate in prostate cancer patients who underwent neoadjuvant chemotherapy using a novel morphometric approach

Journal of Pathology Informatics(2025)10.1016/j.jpi.2025.100528

N/A

0DataRank · unranked

0 citations

Huihua Li, Philipos Tsourkas, Sean J. McIlwain, Irene M. Ong, Christos E. Kyriakopoulos +8 more

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

The Prostate(2020)10.1002/pros.24076

N/A

0DataRank · unranked

36 citations

Mikolaj Filon, Wei Huang, Tom Havighurst, Katina DeShong, KyungMann Kim +9 more

Tandem histone methyltransferase upregulation defines a unique aggressive prostate cancer phenotype

British Journal of Cancer(2021)10.1038/s41416-021-01398-7

N/A

0DataRank · unranked

6 citations

Joseph Gawdzik, Andrew Truong, Glenn O. Allen, Wei Huang, Tariq A. Khemees +6 more

Reversible epigenetic alterations regulate class I HLA loss in prostate cancer

Communications Biology(2022)10.1038/s42003-022-03843-6

N/A

0DataRank · unranked

52 citations

Erika Héninger, Charlotte N. Stahlfeld, Cole S. Gilsdorf, Kristin N. Carlson, Madison Kircher +8 more

Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform

The FASEB Journal(2022)10.1096/fj.202200684rr

N/A

0DataRank · unranked

15 citations

Erika Héninger, Matthew T. Breneman, Emma E. Recchia, Adeline B. Ding, David F. Jarrard +4 more

Fresh tissue procurement and preparation for multicompartment and multimodal analysis of the prostate tumor microenvironment

The Prostate(2022)10.1002/pros.24326

N/A

0DataRank · unranked

5 citations

Wei Huang, Peter Geiger, Erika Héninger, Joshua M. Lang, David F. Jarrard +3 more

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

Oncotarget(2023)10.18632/oncotarget.28477

N/A

0DataRank · unranked

7 citations

Bing Yang, Tanaya A. Purohit, Jennifer L. Schehr, Anupama Singh, Marcelo Bigarella +5 more

Fusion Gene Detection in Prostate Cancer Samples Enhances the Prediction of Prostate Cancer Clinical Outcomes from Radical Prostatectomy through Machine Learning in a Multi-Institutional Analysis

American Journal Of Pathology(2023)10.1016/j.ajpath.2022.12.013

N/A

0DataRank · unranked

7 citations

Silvia Liu, Bao‐Guo Ren, Joel B. Nelson, David F. Jarrard, James D. Brooks +4 more

Elucidating the RNA–Protein Interactomes of Target RNAs in Tissue

Analytical Chemistry(2023)10.1021/acs.analchem.2c05635

N/A

0DataRank · unranked

3 citations

Katherine B. Henke, Bing Yang, Mark Scalf, Brian L. Frey, David F. Jarrard +2 more